Targeted transgene expression in muller glia of normal and diseased retinas using lentiviral vectors.
about
Lentiviral vectors in gene therapy: their current status and future potentialRibonucleic acid interference induced gene knockdownRetinal degeneration progression changes lentiviral vector cell targeting in the retinaIn vivo imaging of microscopic structures in the rat retinaMolecular evolution of adeno-associated virus for enhanced glial gene delivery.Müller cell activation, proliferation and migration following laser injuryGFAP-driven GFP expression in activated mouse Müller glial cells aligning retinal blood vessels following intravitreal injection of AAV2/6 vectorsHigh-efficiency transduction of the mouse retina by tyrosine-mutant AAV serotype vectorsExpression characteristics of dual-promoter lentiviral vectors targeting retinal photoreceptors and Müller cells.Adaptive optics retinal imaging in the living mouse eyeVector platforms for gene therapy of inherited retinopathies.Sox9 is expressed in mouse multipotent retinal progenitor cells and functions in Müller glial cell development.Intravitreal inhibition of complement C5a reduces choroidal neovascularization in mice.Astrocytes regulate adult hippocampal neurogenesis through ephrin-B signaling.Tyrosine-mutated AAV2-mediated shRNA silencing of PTEN promotes axon regeneration of adult optic nerveLet There Be Light: Gene and Cell Therapy for Blindness.Strategies for targeting primate neural circuits with viral vectors.Short hairpin RNA-mediated knockdown of VEGFA in Müller cells reduces intravitreal neovascularization in a rat model of retinopathy of prematurity.Functional promoter testing using a modified lentiviral transfer vectorEffect of endothelial progenitor cells derived from human umbilical cord blood on oxygen-induced retinopathy in mice by intravitreal transplantation.Quantitative analyses of retinal vascular area and density after different methods to reduce VEGF in a rat model of retinopathy of prematurity.Targeting Müller cell-derived VEGF164 to reduce intravitreal neovascularization in the rat model of retinopathy of prematurity.Viral vectors for gene delivery to the central nervous system.Ocular gene delivery using lentiviral vectors.Challenges in neuroprotective nanomedicine development: progress towards noninvasive gene therapy of glaucoma.Recent gene therapy advancements for neurological diseases.Viral Retinopathy in Experimental Models of Zika Infection.Pathophysiology and mechanisms of severe retinopathy of prematurity.Use of lentiviral vectors to deliver and express bicistronic transgenes in developing chicken embryos.Neuroprotective therapies in glaucoma: I. Neurotrophic factor delivery.AAV mediated GDNF secretion from retinal glia slows down retinal degeneration in a rat model of retinitis pigmentosa.Effects of anti-VEGF agents on rat retinal Müller glial cells.A preliminary step of a novel strategy in suicide gene therapy with lentiviral vector.Inhibition of TRB3 Protects Photoreceptors against Endoplasmic Reticulum Stress-Induced Apoptosis after Experimental Retinal Detachment.Gene therapy into photoreceptors and Müller glial cells restores retinal structure and function in CRB1 retinitis pigmentosa mouse models.The transcriptome of retinal Müller glial cellsRetinal transduction profiles by high-capacity viral vectors.Specific tools for targeting and expression in Müller glial cells.Effect of subretinal injection on retinal structure and function in a rat oxygen-induced retinopathy model.
P2860
Q24629462-1A5D258B-9E4D-44B9-B6C0-F2EC940E4477Q26829340-15154B90-7866-4611-8E23-F23B14FE6312Q28741007-0E54A540-8F73-497C-AE13-D4D6C7EC68BBQ33478311-F5404AEA-4DCA-4DB9-ABD5-3FDC01EC1A1EQ33492733-4FE3936D-3394-4002-81BC-3EFA57F5AEE8Q33505318-D978EE42-C1FB-41EF-9EA5-03A59BF229D4Q33680151-6D836BAB-BC0E-4BCF-B87A-AAB3276F855EQ33713361-08991E0F-D88F-4F4C-9992-1F4D1B48893AQ33884609-D357689F-1935-43BA-AD08-3BF000EE27DAQ34264986-937CBE5A-42DB-4892-BDA4-1BFAA6C98781Q34561531-59FB4979-B3F3-4419-82A7-AB41CA6D5EE8Q35546792-177C4C56-6E74-47BA-BBAF-8B7CF1196E8EQ35633511-4AB9D8A5-6708-4B73-A9F2-E2BB7D935584Q36279247-9A13DB0C-2253-43ED-98CB-DF0382DF15EDQ36316471-1BD8FFBA-2CFF-489A-A22D-B4098DAE902DQ36654534-38D953E5-8521-4809-AFB9-C8C0F573263EQ37127728-21EA0380-8012-4A79-85EC-4D26809D5D92Q37149035-A52B482D-8B9D-4284-A28F-61DE87D13932Q37395618-4A5DF51E-E6C1-45BE-B518-F080F411643BQ37485833-2FA0742F-E64B-4320-A7B3-4562F34859A8Q37561227-703FF225-540C-4A87-9728-4DAD66AAF46AQ37577214-1667324D-5972-4149-9793-E3A3022F5F4DQ37946113-C705712D-0CB5-407B-9C9E-0AC6B1E0C9C1Q37952564-7C32BC18-03AD-4641-BD8A-6C53B5702C2CQ38030642-039DBD49-EBFB-4F52-8557-53B4659C09D4Q38085469-572865E9-54EB-4154-827D-96F7A2EC8507Q38156739-7F0DD3B7-F089-4DCA-A0A6-FDD26286B79BQ38274655-E8880178-1481-461E-9F10-2CEA7D20995DQ38420685-A7F4254F-7ADE-467F-8848-4502B193AC82Q38573732-ABD1189A-7486-425D-9A35-16332E6FF4B6Q38585967-C52BF93F-9936-453C-8D62-0BBD8C16D3D8Q40284780-FEB8FF1F-1954-43BD-A10A-25ED7B3781AAQ41965164-63F5551A-92C5-480D-A3EC-D317871F300AQ42149567-A135A938-91BD-4B49-B648-47DBA64FA162Q42161021-906F8310-6778-4B09-BF50-0FF2FD39D13DQ42186126-BB1EF6B2-E755-486C-B4F1-B01661B0FB66Q42208596-BF808BD9-035F-4D9E-96BF-62C32635A998Q42246853-96D8D95D-AAAC-4F44-9021-D852DC667E19Q47113822-3D34F558-739E-467B-93BC-8A8DC52EC9DD
P2860
Targeted transgene expression in muller glia of normal and diseased retinas using lentiviral vectors.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Targeted transgene expression ...... inas using lentiviral vectors.
@ast
Targeted transgene expression ...... inas using lentiviral vectors.
@en
type
label
Targeted transgene expression ...... inas using lentiviral vectors.
@ast
Targeted transgene expression ...... inas using lentiviral vectors.
@en
prefLabel
Targeted transgene expression ...... inas using lentiviral vectors.
@ast
Targeted transgene expression ...... inas using lentiviral vectors.
@en
P2860
P356
P1476
Targeted transgene expression ...... inas using lentiviral vectors.
@en
P2093
Kenneth P Greenberg
Scott F Geller
P2860
P304
P356
10.1167/IOVS.05-1570
P407
P577
2007-04-01T00:00:00Z